Donna Dickman
VICE PRESIDENT, QUALITY

Donna Dickman

Donna Dickman joined Mythic Therapeutics in September 2023 to build out the Quality group and lead all Quality-related activities in support of bringing the company’s lead ADC program to the clinic and to establish the Quality Management Systems within Mythic. Her work at Mythic is informed by her extensive experience in GMP Quality, supporting CMC activities of biologics, Gene/Cell therapy, and antibody-drug conjugates (ADCs), as well as GLP and GCP Quality experience.

Prior to Mythic, Donna was Vice President of Quality at Pyxis Oncology, where she led the Quality team in developing the Quality Management System in support of Phase 1 ADC and mAb programs. Before this, she was Vice President, Quality at Ziopharm Oncology, a cell and gene therapy oncology company, where she worked for eight years. Donna also worked at other companies in the biotechnology space such as TolerRx and Merrimack Pharmaceuticals, as Director of Quality.

Donna has over 25 years of experience working in the biotechnology field with the majority of her experience with oncology focused Phase 1 through Phase 3 companies.